Michael Woudenberg

2024

In 2024, Michael Woudenberg earned a total compensation of $349.2K as Chief Operating Officer at InMed Pharmaceuticals, a 17% increase compared to previous year.

Compensation breakdown

Bonus$54,400
Option Awards$22,800
Salary$272,000
Total$349,200

Woudenberg received $272K in salary, accounting for 78% of the total pay in 2024.

Woudenberg also received $54.4K in bonus and $22.8K in option awards.

Rankings

In 2024, Michael Woudenberg's compensation ranked 117th out of 152 executives tracked by ExecPay. In other words, Woudenberg earned more than 23.0% of executives.

ClassificationRankingPercentile
All
117
out of 152
23rd
Division
Manufacturing
51
out of 66
23rd
Major group
Chemicals And Allied Products
19
out of 26
27th
Industry group
Drugs
19
out of 26
27th
Industry
Pharmaceutical Preparations
17
out of 23
26th
Source: SEC filing on October 28, 2024.

Woudenberg's colleagues

We found five more compensation records of executives working with Michael Woudenberg at InMed Pharmaceuticals in 2024.

2024

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

2024

Eric Hsu

InMed Pharmaceuticals

Senior Vice President, Preclinical Research & Development

2024

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

2024

Netta Jagpal

InMed Pharmaceuticals

Chief Financial Officer

2024

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like